Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Bernard, Debré"'
Autor:
Géraldine Pignot, Ivan Bieche, Sophie Vacher, Catherine Güet, Annick Vieillefond, Bernard Debré, Rosette Lidereau, Delphine Amsellem-Ouazana
Publikováno v:
European Urology. 56:678-689
Actors of the angiogenesis pathways are targets for the new promising targeted therapies already used in several malignancies. In bladder cancer, antiangiogenic molecules could also add to already existing treatment options.To evaluate the involvemen
Publikováno v:
Progrès en Urologie. 17:203-207
Resume Objectif Analyser l’influence du poids de la glande prostatique sur le statut des marges chirurgicales apres prostatectomie. Patients et methodes Une cohorte de 295 patients operes consecutivement entre 1998 et 2004 dans notre institution a
Autor:
Sengül Tozlu, Annick Vieillefond, Henry Botto, Ivan Bièche, Delphine Amsellem-Ouazana, Caroline Elie, Bernard Debré, Rosette Lidereau, Vincent Molinié
Publikováno v:
European Urology. 49:1035-1043
Objective To test different approaches of evaluation of the ErbB2 status in a large series of human transitional cell carcinoma (TCC) of the bladder with the prospect of finding targeted therapies. Methods ErbB2 status of 73 human TCC samples was ana
Autor:
Ivan Bièche, Rosette Lidereau, Delphine Amsellem-Ouazana, Sengiil Tozlu, Bernard Debré, Henry Botto
Publikováno v:
Journal of Urology. 175:1127-1132
The ErbB driven growth pathway has been implicated in most human epithelial malignancies. Therefore, its blockade is a promising therapeutic strategy and several candidate drugs are currently undergoing clinical trials. Paradoxically little is known
Autor:
Bernard Debré, Nicolas Barry Delongchamps, Michaël Peyromaure, Kaili Mao, Hang Theng, Marc Zerbib
Publikováno v:
European Urology. 48:946-950
Objectives To analyze the outcome of patients after fortuitous diagnosis of prostate cancer (PCa) on cystoprostatectomy (CPT) specimen. Methods The medical charts of 141 male patients who underwent radical CPT for urothelial cell carcinoma of the bla
Autor:
Marc Zerbib, Thierry Flam, Philippe Beuzeboc, Loïc Guillevin, Jérôme Alexandre, Stanislas Ropert, Delphine Amsellem-Ouazana, François Goldwasser, Olivier Mir, Bernard Debré
Publikováno v:
Anti-Cancer Drugs. 16:1017-1021
Clinical trials in urothelial cancer exclude a large population of patients. An observational study evaluated the behavior of frail patients not eligible for cisplatin- or carboplatin-based regimens. Urothelial cancer patients requiring chemotherapy
Autor:
Anh Tuan Dinh-Xuan, Claire Goulvestre, Yvonne Fulla, Bernard Debré, Michaël Peyromaure, Sophie Grabar
Publikováno v:
Urology. 66:687-691
Objectives To analyze the correlation between serum levels of vascular endothelial growth factor (VEGF) and biopsy findings in patients with a suspicion of prostate cancer. Methods Serum levels of VEGF were measured on frozen, archival serum obtained
Autor:
Marc Zerbib, Thierry Flam, Mickaël Peyromaure, Delphine Amsellem-Ouazana, Patrick Younes, Bernard Debré, S. Conquy
Publikováno v:
European Urology. 47:582-586
Objective: Repeated biopsies in patients with a high risk of prostate cancer only allow a small proportion of new cancer diagnosis. The aim of this study was to evaluate the use of combined MRI and magnetic resonance spectroscopy imaging (MRSI) for t
Publikováno v:
Urology. 65:724-729
Objectives To analyze the oncologic results of intermittent androgen deprivation (IAD) for biochemical recurrence after radical prostatectomy (RP). Methods A total of 57 patients with biochemical recurrence after RP have been treated with IAD at our
Autor:
Bernard Debré, Michaël Peyromaure
Publikováno v:
Bulletin de l'Académie Nationale de Médecine. 189:123-134
RESUME La cystectomie radicale est le traitement de reference du cancer infiltrant de vessie non metastatique. Aujourd’hui, la majorite des patients beneficient d’une enteroplastie de substitution apres cystectomie. La derivation trans-ileale de